Tus kws kho mob
QP95-21 Update for New to Market Medical Drugs: triamcinolone acetonide injectable suspension (Xipere) and vutrisiran
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 08, 2021
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1341 - 1350 ntawm 4303
Tus kws kho mob
QP96-21 Processing Change for HCPCS Code A9279
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 08, 2021
Tus kws kho mob
QP97-21 MHCP Pharmacy Benefit Exclusion for Asparlas™, Khapzory™, Nulojix®, Oncaspar® and Susvimo™
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 08, 2021
Tus kws kho mob
QP98-21 Commercial Pharmacy Benefit Exclusion for Nulojix® and Susvimo™
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 08, 2021
Tus kws kho mob
QP99-21 Blue Cross and Blue Shield of Minnesota Collaboration with VillageHealth
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 08, 2021
Tus kws kho mob
QP100-21 Checks to be Sent for Unpaid Prompt Pay Penalties
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 08, 2021
Tus kws kho mob
QP101-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective February 1, 2022
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 08, 2021
Tus kws kho mob
2021 December Provider Press
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 03, 2021
Tus kws kho mob
BCBSMN-Upcoming-policies-effective-013122.pdf